---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-020410"
form_type: "8-K"
ticker: "ENVB"
cik: "0000890821"
company_name: "Enveric Biosciences, Inc."
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T01:26:01.725039+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Enveric corrects proxy error: reverse split ratio range is 1-for-5 to 1-for-15, not 1-for-50

## Summary
- Corrected reverse split range from erroneously stated 1-for-50 to correct 1-for-15 in proxy statement.
- Error appeared on proxy card and notice of internet availability; other proposal text was correct.
- Meeting details (May 28, 2026, virtual, all proposals) remain unchanged; supplemental filing made April 30.

## SEC filing metadata
- accession: 0001493152-26-020410
- form_type: 8-K
- ticker: ENVB
- cik: 0000890821
- company_name: Enveric Biosciences, Inc.
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/890821/000149315226020410/0001493152-26-020410-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/890821/000149315226020410/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-020410
- JSON: https://secwatch.observer/filing/0001493152-26-020410.json
- Plain text: https://secwatch.observer/filing/0001493152-26-020410.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.